Untitled

Transcriptional Regulation in Schizophrenia 119cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia.Neuroscience, 78(1), 99–110.Humphries, C., Mortimer, A., Hirsch, S., & de Belleroche, J. (1996). NMDA receptormRNA correlation with antemortem cognitive impairment in schizophrenia. Neuroreport,7(12), 2051–2055.Imai, K., Harada, S., Kawanishi, Y., Tachikawa, H., Okubo, T., & Suzuki, T. (2001).Polymorphisms in the promoter and coding regions of the synapsin III gene. A lack ofassociation with schizophrenia. Neuropsychobiology, 43(4), 237–241.Isohanni, M., Isohanni, I., Koponen, H., Koskinen, J., Laine, P., Lauronen, E., et al.(2004). Developmental precursors of psychosis. Current Psychiatry Report, 6(3),168–175.Jacobsen, L. K., Giedd, J. N., Castellanos, F. X., Vaituzis, A. C., Hamburger, S. D., Kumra,S., et al. (1998). Progressive reduction of temporal lobe structures in childhood-onsetschizophrenia. American Journal of Psychiatry, 155(5), 678–685.Jakob, H., & Beckmann, H. (1986). Prenatal developmental disturbances in the limbicallocortex in schizophrenics. Journal of Neural Transmission, 65(3–4), 303–326.James, A. C., James, S., Smith, D. M., & Javaloyes, A. (2004). Cerebellar, prefrontal cortex,and thalamic volumes over two time points in adolescent-onset schizophrenia. AmericanJournal of Psychiatry, 161(6), 1023–1029.Javitt, D. C., & Zukin, S. R. (1991). Recent advances in the phencyclidine model of schizophrenia.American Journal of Psychiatry, 148(10), 1301–1308.Jonas, P., Racca, C., Sakmann, B., Seeburg, P. H., & Monyer, H. (1994). Differences inCa2+ permeability of AMPA-type glutamate receptor channels in neocortical neuronscaused by differential Glur-B subunit expression. Neuron, 12(6), 1281–1289.Keshavan, M. S., Stanley, J. A., Montrose, D. M., Minshew, N. J., & Pettegrew, J. W.(2003). Prefrontal membrane phospholipid metabolism of child and adolescent offspringat risk for schizophrenia or schizoaffective disorder: An in vivo 31P MRS study. MolecularPsychiatry, 8(3), 316–323, 251.Klingberg, T., Roland, P. E., & Kawashima, R. (1994). The human entorhinal cortex participatesin associative memory. Neuroreport, 6(1), 57–60.Koenig, J. I., Kirkpatrick, B., & Lee, P. (2002). Glucocorticoid hormones and early braindevelopment in schizophrenia. Neuropsychopharmacology, 27(2), 309–318.Koike, M., Tsukada, S., Tsuzuki, K., Kijima, H., & Ozawa, S. (2000). Regulation of kineticproperties of GluR2 AMPA receptor channels by alternative splicing. Journal ofNeuroscience, 20(6), 2166–2174.Koltchine, V. V., Anantharam, V., Bayley, H., & Treistman, S. N. (1996). Alternativesplicing of the NMDAR1 subunit affects modulation by calcium. Brain ResearchMolecular Brain Research, 39(1–2), 99–108.Konradi, C., & Heckers, S. (2003). Molecular aspects of glutamate dysregulation: Implicationsfor schizophrenia and its treatment. Pharmacology and Therapeutics, 97(2),153–179.Lahti, A. C., Koffel, B., LaPorte, D., & Tamminga, C. A. (1995). Subanesthetic doses ofketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology, 13(1), 9–19.Law, A. J., Weickert, C. S., Webster, M. J., Herman, M. M., Kleinman, J. E., & Harrison,P. J. (2003). Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAsduring development of the human hippocampal formation. European Journal of Neuroscience,18(5), 1197–1205.Lawrie, S. M., Whalley, H. C., Abukmeil, S. S., Kestelman, J. N., Miller, P., Best, J. J.,